Skip to main content

Advertisement

Log in

In vivo detection demonstrates circulating tumor cell reduction instead of baseline number has prognostic value in bladder cancer patients receiving neoadjuvant chemotherapy

  • Brief Report
  • Published:
Cellular Oncology Aims and scope Submit manuscript

Abstract

Purpose

Previous studies have suggested the potential prognostic value of circulating tumor cells (CTCs) in bladder cancer (BC) patients. This study aims to validate the prognostic value of in vivo detection of CTCs in muscle invasive bladder cancer (MIBC) patients receiving neoadjuvant chemotherapy (NAC).

Methods

A total of 107 MIBC patients were enrolled in this study. All patients had one in vivo detection of CTCs before initial treatment as baseline, and those who received neoadjuvant chemotherapy (NAC) had a second detection after NAC and before radical cystectomy. CTCs dynamic change after NAC was analyzed. Prognostic value of in vivo CTCs detection was investigated.

Results

Among 68 patients who received NAC, 45 patients (66%) had a CTC reduction after NAC. CTC reduction instead of baseline CTC positivity was a key prognostic factor for better progression free survival (PFS) among all MIBC patients receiving NAC in Kaplan–Meier analysis (P < 0.01) and in both crude (HR 6.14, 95%CI 1.63–23.21) and adjusted regression model (HR 6.76, 95% CI 1.59–28.88). The AUC was 0.85.

Conclusion

Our study demonstrated the prognostic value of in vivo detection of CTCs. The dynamic change of CTCs count may help evaluate the efficacy of NAC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. R.L. Siegel, K.D. Miller, H.E. Fuchs, A. Jemal, CA Cancer J Clin 72, 7–33 (2022). https://doi.org/10.3322/caac.21708

    Article  PubMed  Google Scholar 

  2. A.T. Lenis, P.M. Lec, K. Chamie, M.D. Mshs, JAMA 324, 1980–1991 (2020). https://doi.org/10.1001/jama.2020.17598

  3. J.A. Witjes, H.M. Bruins, R. Cathomas, E.M. Comperat, N.C. Cowan, G. Gakis, V. Hernandez, E. Linares Espinos, A. Lorch, Y. Neuzillet, M. Rouanne, G.N. Thalmann, E. Veskimae, M.J. Ribal, A.G. van der Heijden, Eur. Urol. 79, 82–104 (2021). https://doi.org/10.1016/j.eururo.2020.03.055

    Article  CAS  PubMed  Google Scholar 

  4. International Collaboration of Trialists on behalf of the Medical Research Council Advanced Bladder Cancer Working Party (now the National Cancer Research Institute Bladder Cancer Clinical Studies Group), the European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group, the Australian Bladder Cancer Study Group, the National Cancer Institute of Canada Clinical Trials Group, Finnbladder, Norwegian Bladder Cancer Study Group, and Club Urologico Espanol de Tratamiento Oncologico Group, J. Clin. Oncol. 29, 2171–2177 (2011). https://doi.org/10.1200/JCO.2010.32.3139

  5. A.C. Small, Y. Gong, W.K. Oh, S.J. Hall, C.J. van Rijn, M.D. Galsky, J. Urol. 188, 21–26 (2012). https://doi.org/10.1016/j.juro.2012.02.2558

    Article  PubMed  Google Scholar 

  6. H. Jiang, X. Gu, Z. Zuo, G. Tian, J. Liu, PLoS One 16, e0254433 (2021). https://doi.org/10.1371/journal.pone.0254433

  7. B. Hong, Y. Zu, Theranostics 3, 377–394 (2013). https://doi.org/10.7150/thno.5195

  8. O. Vermesh, A. Aalipour, T.J. Ge, Y. Saenz, Y. Guo, I.S. Alam, S.M. Park, C.N. Adelson, Y. Mitsutake, J. Vilches-Moure, E. Godoy, M.H. Bachmann, C.C. Ooi, J.K. Lyons, K. Mueller, H. Arami, A. Green, E.I. Solomon, S.X. Wang, S.S. Gambhir, Nat. Biomed. Eng. 2, 696–705 (2018). https://doi.org/10.1038/s41551-018-0257-3

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. J. Budna-Tukan, M. Swierczewska, M. Mazel, W.A. Cieslikowski, A. Ida, A. Jankowiak, A. Antczak, M. Nowicki, K. Pantel, D. Azria, M. Zabel, C. Alix-Panabieres, Cancers (Basel) 11, (2019). https://doi.org/10.3390/cancers11060802

  10. S. Chen, G. Tauber, T. Langsenlehner, L.M. Schmolzer, M. Potscher, S. Riethdorf, A. Kuske, G. Leitinger, K. Kashofer, Z.T. Czyz, B. Polzer, K. Pantel, P. Sedlmayr, T. Kroneis, A. El-Heliebi, Cancers (Basel) 11, (2019). https://doi.org/10.3390/cancers11070933

  11. E.P. Darga, E.M. Dolce, F. Fang, K.M. Kidwell, C.L. Gersch, S. Kregel, D.G. Thomas, A. Gill, M.E. Brown, S. Gross, M. Connelly, M. Holinstat, E.F. Cobain, J.M. Rae, D.F. Hayes, C. Paoletti, PLoS One 16, e0260124 (2021). https://doi.org/10.1371/journal.pone.0260124

  12. S.J. Cohen, C.J. Punt, N. Iannotti, B.H. Saidman, K.D. Sabbath, N.Y. Gabrail, J. Picus, M.A. Morse, E. Mitchell, M.C. Miller, G.V. Doyle, H. Tissing, L.W. Terstappen, N.J. Meropol, Ann. Oncol. 20, 1223–1229 (2009). https://doi.org/10.1093/annonc/mdn786

    Article  CAS  PubMed  Google Scholar 

  13. Y. Han, D. Liu, L. Li, Am. J. Cancer Res. 10, 727–742 (2020)

    CAS  PubMed  PubMed Central  Google Scholar 

  14. J. Abrahamsson, K. Aaltonen, H. Engilbertsson, F. Liedberg, O. Patschan, L. Ryden, G. Sjodahl, S. Gudjonsson, Urol. Oncol. 35, 606.e609-606.e616 (2017). https://doi.org/10.1016/j.urolonc.2017.05.021

  15. P. Gazzaniga, E. de Berardinis, C. Raimondi, A. Gradilone, G.M. Busetto, E. De Falco, C. Nicolazzo, R. Giovannone, V. Gentile, E. Cortesi, K. Pantel, Int. J. Cancer 135, 1978–1982 (2014). https://doi.org/10.1002/ijc.28830

    Article  CAS  PubMed  Google Scholar 

  16. M. Rink, F.K. Chun, R. Dahlem, A. Soave, S. Minner, J. Hansen, M. Stoupiec, C. Coith, L.A. Kluth, S.A. Ahyai, M.G. Friedrich, S.F. Shariat, M. Fisch, K. Pantel, S. Riethdorf, Eur. Urol. 61, 810–817 (2012). https://doi.org/10.1016/j.eururo.2012.01.017

    Article  CAS  PubMed  Google Scholar 

  17. M. Rink, F.K. Chun, S. Minner, M. Friedrich, O. Mauermann, H. Heinzer, H. Huland, M. Fisch, K. Pantel, S. Riethdorf, BJU Int. 107, 1668–1675 (2011). https://doi.org/10.1111/j.1464-410X.2010.09562.x

    Article  PubMed  Google Scholar 

  18. A. Soave, S. Riethdorf, R. Dahlem, S. Minner, L. Weisbach, O. Engel, M. Fisch, K. Pantel, M. Rink, BJU Int. 119, 854–861 (2017). https://doi.org/10.1111/bju.13782

    Article  PubMed  Google Scholar 

  19. A. Zapatero, A. Gomez-Caamano, M.A. Cabeza Rodriguez, L. Muinelo-Romay, C. Martin de Vidales, A. Abalo, P. Calvo Crespo, L. Leon Mateos, C. Olivier, and L.V. Vega Piris, Radiat Oncol 15, 137 (2020). https://doi.org/10.1186/s13014-020-01577-5

    Article  CAS  Google Scholar 

  20. H.L. Wang, J.Q. Wu, Y. Wang, J. Yu, X.N. Mao, Z.R. Li, H.R. Niu, C.L. Jin, X.J. Wang, Z.H. Yan, L. Yi, B. Yang, P.J. Wei, H.T. Zhang, S.C. Zhang, Neoplasma 68, 823–831 (2021). https://doi.org/10.4149/neo_2021_210115N67

    Article  CAS  PubMed  Google Scholar 

  21. A. Alva, T. Friedlander, M. Clark, T. Huebner, S. Daignault, M. Hussain, C. Lee, K. Hafez, B. Hollenbeck, A. Weizer, G. Premasekharan, T. Tran, C. Fu, C. Ionescu-Zanetti, M. Schwartz, A. Fan, P. Paris, J. Urol. 194, 790–798 (2015). https://doi.org/10.1016/j.juro.2015.02.2951

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. W.T. Yan, X. Cui, Q. Chen, Y.F. Li, Y.H. Cui, Y. Wang, J. Jiang, Sci. Rep. 7, 43464 (2017). https://doi.org/10.1038/srep43464

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. D. Olmos, H.T. Arkenau, J.E. Ang, I. Ledaki, G. Attard, C.P. Carden, A.H. Reid, R. A’Hern, P.C. Fong, N.B. Oomen, R. Molife, D. Dearnaley, C. Parker, L.W. Terstappen, J.S. de Bono, Ann. Oncol. 20, 27–33 (2009). https://doi.org/10.1093/annonc/mdn544

    Article  CAS  PubMed  Google Scholar 

  24. T. Jiang, J. Zhao, C. Zhao, X. Li, J. Shen, J. Zhou, S. Ren, C. Su, C. Zhou and M. O’Brien, Clin Lung Cancer 20, 124–133 e122 (2019). https://doi.org/10.1016/j.cllc.2018.11.014

  25. L. Dizdar, G. Fluegen, G. van Dalum, E. Honisch, R.P. Neves, D. Niederacher, H. Neubauer, T. Fehm, A. Rehders, A. Krieg, W.T. Knoefel, N.H. Stoecklein, Mol. Oncol. 13, 1548–1558 (2019). https://doi.org/10.1002/1878-0261.12507

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This work was supported by the National Natural Science Foundation of China (82173076, 82103485), Shanghai Natural Science Foundation (20Y11904900), Young Talent Project in Healthcare of Shanghai Municipal Health Commission (2022YQ014), Shanghai Hospital Development Center (SHDC2022CRD034) and Innovative Research Team of High-level Local Universities in Shanghai.

Author information

Authors and Affiliations

Authors

Contributions

Di Jin, Liang Dong, and Haige Chen designed studies, analyzed, and wrote the manuscript. Di Jin, Lei Qian, Jun Xia, and Ming Cao conducted the experiments and data analysis. Guoliang Yang, Ruiyun Zhang, Lianhua Zhang and Wei Xue collected the patient samples, follow-up information, and performed the clinical data analysis. Lei Qian and Liang Dong prepared figures and table. All authors reviewed and approved the final manuscript.

Corresponding authors

Correspondence to Cao Ming, Dong Liang or Chen Haige.

Ethics declarations

Ethical approval

The study complies with the Declaration of Helsinki and was conducted following the approval from Renji Hospital Ethics Committee. Written informed consent was obtained from all the patients.

Competing interests

The authors have no competing interests to declare that are relevant to the content of this article.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jin, D., Qian, L., Xia, J. et al. In vivo detection demonstrates circulating tumor cell reduction instead of baseline number has prognostic value in bladder cancer patients receiving neoadjuvant chemotherapy. Cell Oncol. 46, 793–797 (2023). https://doi.org/10.1007/s13402-023-00785-x

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13402-023-00785-x

Keywords

Navigation